Document is current
Any future updates will be listed below
-
Authors
Love, Sharon B. https://orcid.org/0000-0002-6695-5390
Kilanowski, Anna https://orcid.org/0000-0001-5328-6274
Yorke-Edwards, Victoria https://orcid.org/0000-0002-6465-7330
Old, Oliver
Barr, Hugh
Stokes, Clive
Kendall, Catherine
Sydes, Matthew R. https://orcid.org/0000-0002-9323-1371
-
Funding
Funding for this research was provided by:
Medical Research Council (UU 12023/24)
- License Information
-
More Information
Article History
Received: 12 August 2020
Accepted: 8 September 2021
First Online: 26 September 2021
Declarations
:
: The BOSS trial was approved by the UCLH Research Ethics Committee Alpha in 2008 and approvals from all hosting NHS organisations for each site were collected. The flagging in the NHS Digital system and following data collection was already included in the first informed consent. The approval for the use of trial data in this study was given by the Chief Investigator and the Data Monitoring Committee.
: Not applicable.
: MS reports grants and non-financial support from Astellas, grants from Clovis, grants and non-financial support from Janssen, grants and non-financial support from Novartis, grants and non-financial support from Sanofi, grants and non-financial support from Sanofi, personal fees from Lilly Oncology and personal fees from Janssen, outside the submitted work. HB and CK report the NIHR HTA grant for the BOSS trial. The remaining authors declare that they have no competing interests.
